XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Business, Presentation and Recent Accounting Pronouncements (Details)
3 Months Ended 9 Months Ended
Aug. 31, 2025
USD ($)
Aug. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Subsidiary, Sale of Stock [Line Items]              
Cash and cash equivalents     $ 5,508,899   $ 5,508,899   $ 3,792,322
Short-term investments     13,866,546   13,866,546   22,999,760
Accumulated deficit     147,700,755   147,700,755   143,382,122
Tangible asset impairment         0    
In-process R&D impairment     0 $ 2,008,000 $ 0 $ 2,008,000  
Number of business segments | segment         1    
Number of geographic areas | segment         3    
Income taxes receivable     400,000   $ 400,000   200,000
In Process R&D              
Subsidiary, Sale of Stock [Line Items]              
In-process R&D impairment $ 0 $ 2,000,000.0          
Indefinite-lived intangible assets     $ 6,700,000   $ 6,700,000   $ 6,700,000